Epidermolysis bullosa – Diagnostics – Overview of Information and Clinical Research

Epidermolysis bullosa is a rare genetic condition that makes the skin incredibly fragile, causing it to blister and tear from even the slightest touch or friction. Understanding how this condition is diagnosed helps families recognize symptoms early and access the specialized care their child needs.

Introduction: Who Should Seek Diagnostics

If you notice that your baby or young child develops blisters without a clear cause, especially after minimal contact or rubbing, it is important to contact your pediatrician right away. Epidermolysis bullosa usually shows symptoms at birth or during infancy, though some milder forms may not become obvious until a child starts crawling or walking, when friction on the skin increases.^[1] In rare cases, symptoms may not appear until adolescence or adulthood.^[3]

Parents should seek medical evaluation if they observe skin that blisters very easily, particularly on the hands, feet, knees, or elbows. Other warning signs include blisters inside the mouth, difficulty swallowing, thickened or missing fingernails and toenails, or skin that appears unusually thin and fragile.^[1] In severe cases, blisters may form in the throat or digestive system, leading to feeding difficulties and poor weight gain in infants.^[2]

Anyone experiencing these symptoms, regardless of age, should be evaluated by a healthcare provider. Early diagnosis allows families to learn proper wound care techniques, prevent complications such as infections, and connect with support networks. Because this condition affects the entire family, getting a correct diagnosis is the first step toward managing the physical, emotional, and financial challenges that come with epidermolysis bullosa.^[5]

⚠️ Important

Always seek immediate medical attention if your child shows signs of infection such as fever, unusual warmth or redness around blisters, pus or discharge from wounds, or if they have problems swallowing or breathing. These can be serious complications that require urgent care.

Diagnostic Methods

Diagnosing epidermolysis bullosa begins with a careful examination of the skin and a detailed medical history. A healthcare provider may initially suspect the condition based on how the skin looks and behaves. However, because there are many subtypes of epidermolysis bullosa with different causes and severities, additional testing is necessary to confirm the diagnosis and identify the specific type.^[9]

Physical Examination

The first step in diagnosis is a thorough physical examination. A dermatologist, a doctor who specializes in skin conditions, will examine the blisters, their location, and how easily they form. They will look at whether blisters appear only on certain parts of the body or all over, whether they leave scars after healing, and whether other areas like the mouth, eyes, or nails are affected.^[3] This visual assessment helps narrow down which type of epidermolysis bullosa might be present.

Skin Biopsy with Immunofluorescence Mapping

To confirm the diagnosis and determine the exact type of epidermolysis bullosa, doctors typically perform a skin biopsy, which means taking a small sample of affected skin for laboratory examination. This is one of the most important diagnostic tests for this condition.^[9] The sample is usually taken from an area where a fresh blister has formed, as this provides the clearest information.

The skin sample is examined using a technique called immunofluorescence mapping. This specialized method uses reflected light under a microscope to identify which layers of the skin are involved in the blistering. It can show whether the separation between skin layers is happening in the top layer of skin (the epidermis), the bottom layer (the dermis), or in the junction where these layers meet.^[9] This test also checks whether the proteins that normally hold the skin layers together are present and functioning properly.^[2]

Genetic Testing

Genetic testing is now considered the preferred method for diagnosing epidermolysis bullosa and identifying the specific genetic mutation responsible for the condition.^[8]^[12] This test involves taking a small sample of blood or, in some cases, saliva, and sending it to a specialized laboratory for DNA analysis.^[9]

Scientists have identified mutations in at least 16 to 20 different genes that can cause epidermolysis bullosa.^[4]^[6] These genes provide instructions for making proteins such as collagen type VII, keratin 5 or 14, and laminin-332, which are essential for anchoring the layers of skin together.^[5] When these proteins are missing or defective, the skin loses its ability to withstand normal friction and pressure.

Genetic testing not only confirms the diagnosis but also provides valuable information about the inheritance pattern of the condition. Some types of epidermolysis bullosa are autosomal dominant, meaning a child needs to inherit the faulty gene from only one parent to develop the condition. Other types are autosomal recessive, meaning the child must inherit a faulty gene from both parents, even if the parents themselves show no symptoms.^[4] Understanding the genetic basis helps families understand the risk of passing the condition to future children.

Prenatal Testing

For families with a history of epidermolysis bullosa, prenatal testing may be offered to determine whether an unborn baby has inherited the condition. This testing can be performed after the 11th week of pregnancy.^[3] Two main procedures are used: amniocentesis, which involves collecting a sample of the fluid surrounding the baby, and chorionic villus sampling, which takes a small sample of tissue from the placenta.^[3]

Prenatal testing is typically offered when one or both parents are known to carry a faulty gene associated with epidermolysis bullosa, particularly if there is a risk of having a child with a severe form of the condition. If the test confirms that the baby will have epidermolysis bullosa, families are provided with counseling and information to help them prepare for the birth and arrange for specialized care.^[3]

Distinguishing from Other Conditions

It is important for doctors to distinguish epidermolysis bullosa from other conditions that also cause blistering. These include bullous pemphigoid and pemphigus vulgaris, which are autoimmune conditions, as well as simple friction blisters and reactions to insect bites.^[4] The combination of clinical examination, skin biopsy with immunofluorescence, and genetic testing allows healthcare providers to make an accurate diagnosis and rule out other possible causes of skin fragility.

Diagnostics for Clinical Trial Qualification

When patients with epidermolysis bullosa are considered for enrollment in clinical trials, additional diagnostic testing may be required beyond what is needed for standard diagnosis. Clinical trials are research studies that test new treatments, and they have specific criteria that participants must meet to ensure the study results are accurate and meaningful.

For clinical trial participation, researchers typically require confirmation of the specific type and subtype of epidermolysis bullosa through genetic testing. This ensures that the trial is evaluating the treatment in patients with the exact genetic mutations that the therapy is designed to address.^[15] For example, trials testing gene therapy for dystrophic epidermolysis bullosa specifically look for patients with mutations in the COL7A1 gene, which provides instructions for making collagen type VII.^[16]

Baseline assessments are also standard requirements before enrolling in a clinical trial. These may include detailed wound assessments to measure the total surface area of the body affected by blisters and open wounds. Photographs and measurements help researchers track whether the treatment improves wound healing over time. Some trials may also require blood tests to check for anemia, nutritional deficiencies, or markers of inflammation, all of which are common complications in epidermolysis bullosa.^[6]

Trials may also include quality-of-life questionnaires and pain assessments to understand how the condition affects daily life and whether the treatment provides meaningful benefits beyond just physical healing. Depending on the type of trial, additional specialized tests might be needed, such as endoscopy to examine the digestive tract if the trial is studying treatments for internal blistering, or skin biopsies to analyze changes at the cellular level after treatment.^[15]

Families interested in clinical trials should discuss with their healthcare team whether their child meets the specific eligibility criteria. Each trial has unique requirements based on the treatment being studied, the age of participants, the severity of the condition, and other health factors. Access to clinical trials may offer hope for new therapies while advancing scientific understanding of epidermolysis bullosa.

Prognosis and Survival Rate

Prognosis

The prognosis for people with epidermolysis bullosa varies greatly depending on the type and severity of the condition. Mild forms, such as some types of epidermolysis bullosa simplex, may cause discomfort and require careful skin management but generally do not shorten life expectancy. Many people with mild forms see improvement with age, and blisters may become less frequent as they grow older.^[1]^[2]

Severe forms of epidermolysis bullosa, particularly junctional and dystrophic types, carry a higher risk of serious complications. These can include severe infections from open wounds, malnutrition due to blistering in the mouth and esophagus, breathing difficulties, dehydration, and anemia. Repeated blistering and scarring can lead to deformities of the hands and feet, making movement difficult. People with severe dystrophic epidermolysis bullosa are also at significantly increased risk of developing an aggressive type of skin cancer called squamous cell carcinoma, often at a young age.^[2]^[6]

The most severe forms of junctional epidermolysis bullosa can be fatal during infancy due to complications such as widespread infection (sepsis), blockage of the airways, or severe fluid and nutritional losses.^[2]^[8] However, with advances in wound care, nutritional support, and multidisciplinary medical management, many children with epidermolysis bullosa are living longer and with better quality of life than in previous generations.

Survival Rate

Life expectancy for people with epidermolysis bullosa depends heavily on which type they have. Those with mild forms of epidermolysis bullosa simplex typically have a normal life expectancy.^[2] However, people with severe forms of the disease face reduced life expectancy, with survival ranging from infancy to approximately 30 years of age in the most severe cases.^[2]^[20]

The most severe form of junctional epidermolysis bullosa, sometimes called Herlitz type, is often fatal within the first year of life.^[8] For severe recessive dystrophic epidermolysis bullosa, the primary cause of death in adolescence and adulthood is aggressive squamous cell carcinoma of the skin.^[6]^[15] Early and intensive management of wounds, infections, nutrition, and other complications can improve outcomes and extend survival for many patients with severe forms of epidermolysis bullosa.

#1 Clinical Trials Search in Europe